eIF signalling is regulated upstream via the PI3K/AKT/mTOR pathway [17] which has previously been demonstrated to be increasingly activated and dysregulated in astrocytomas (WHO grade I-IV) [18, 24]. The gene discussed is MTOR; the disease is astrocytoma (excluding glioblastoma).